Primary Recipient

OPTIMUM THERAPEUTICS LLC

Amount

$400,000.00

Award Date

9/29/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Non-muscle invading bladder cancer, due to its extra-systemic and easily accessible location (i.e., surface of the bladder cavity) and its early diagnosis, is one of the least lethal cancers. However, recurrence is common and is sometimes accompanied by p

Recipients Connected to Award

Recipient	Role	Amount
SOUTHERN RESEARCH INSTITUTE	Sub-recipient	$252,729.00
OPTIMUM THERAPEUTICS LLC	Primary recipient	$147,271.00